| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A GLOBAL CONGRESS DIGEST ON IMMUNE-DIRECTED THERAPIES IN HODGKIN LYMPHOMA. Report from the International Symposium on Hodgkin lymphoma (ISHL12), 22nd–24th October 2022 (hybrid)
|
|
|
|
15 |
Suppl 5 |
p. 205-212
|
artikel
|
| 2 |
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ASCO Hybrid Congress, 3rd – 7th June 2022
|
|
|
|
15 |
Suppl 5 |
p. 81-98
|
artikel
|
| 3 |
Best of ASCO 2022—central nervous system tumors
|
Leibetseder, Annette
|
|
|
15 |
Suppl 5 |
p. 269-272
|
artikel
|
| 4 |
Breast Cancer—Essential news of current guidelines
|
Strasser-Weippl, Kathrin
|
|
|
15 |
Suppl 5 |
p. 117-120
|
artikel
|
| 5 |
Essential news of current guidelines: head and neck squamous cell carcinoma
|
Fuereder, Thorsten
|
|
|
15 |
Suppl 5 |
p. 278-281
|
artikel
|
| 6 |
From morphology to molecular targets—the pathologist’s view in diagnosing gastroenteropancreatic neuroendocrine neoplasms
|
Henzinger, Hanna
|
|
|
15 |
Suppl 5 |
p. 287-293
|
artikel
|
| 7 |
Hepatocellular carcinoma—neoadjuvant systemic and local treatment concepts to improve resectability rates and oncological outcome
|
Urban, Iveta
|
|
|
15 |
Suppl 5 |
p. 5-11
|
artikel
|
| 8 |
Molecular profiling in colorectal cancer
|
Piringer, Gudrun
|
|
|
15 |
Suppl 5 |
p. 206-210
|
artikel
|
| 9 |
Palliative care: patient’s autonomy in the end-of-life situation
|
Engelhardt, Bert
|
|
|
15 |
Suppl 5 |
p. 76-78
|
artikel
|
| 10 |
Real time experience applying CAR T-cells for B-cell lymphoma—What we have learned so far: Acute toxicity management
|
Kaynak, Emine
|
|
|
15 |
Suppl 5 |
p. 180-184
|
artikel
|
| 11 |
Renal cell carcinoma—presentation highlights from the ESMO Congress 2021
|
Hutterer, Georg C.
|
|
|
15 |
Suppl 5 |
p. 102-106
|
artikel
|
| 12 |
The outcome of COVID-19 in patients with hematological malignancy
|
Tığlıoğlu, Pınar
|
|
|
15 |
Suppl 5 |
p. 83-89
|
artikel
|
Tijdschrift beschrijving